Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2011
10/27/2011US20110263042 Assay method for antibodies against cyclic citrullinated peptide
10/27/2011US20110263035 Determining oxygen concentration in ullage using catalytic oxidation
10/27/2011US20110263033 Apparatus And Methods For Performing Photoreactions And Analytical Methods And Devices To Detect Photo-Reacting Compounds
10/27/2011US20110263032 Testing Mechanical Hardware for Wear and a Composition
10/27/2011US20110263030 Centrifugal micro-fluidic device and method for detecting analytes from liquid specimen
10/27/2011US20110263006 Integrated test strip container with retaining insert
10/27/2011US20110262968 Antibodies that bind to psca proteins for diagnosis of cancer
10/27/2011US20110262964 Reagentless fluorescent biosensors comprising a designed ankyrin repeat protein module, rational design methods to create reagentless fluorescent biosensors and methods of their use
10/27/2011US20110262948 Methods of Quantifying Methotrexate Metabolites
10/27/2011US20110262941 Predicting mortality and detecting severe disease
10/27/2011US20110262940 Capillary for immunoassay, and capillary immunoassay method using same
10/27/2011US20110262939 Methods and assays for classifying foodstuff and/or beverage and/or diet and/or nutrition regimen and/or medicament in view of an effect on the cardiovascular system
10/27/2011US20110262938 Determination of the amount of hLHB core fragment in a sample from a subject and uses thereof
10/27/2011US20110262937 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
10/27/2011US20110262935 Method for detecting a prion infection
10/27/2011US20110262933 Compositions and method for isolating mid-log phase bacteria
10/27/2011US20110262932 Compositions
10/27/2011US20110262931 Mast cell carboxypeptidase as a marker for anaphylaxis and mastocytosis
10/27/2011US20110262926 Extracting low concentrations of bacteria from a sample
10/27/2011US20110262925 Methods for isolating a target analyte from a heterogeneous sample
10/27/2011US20110262923 Method for the quantitative determination of the number of copies of a predetermined sequence in a sample
10/27/2011US20110262922 Aptamer sandwich assays
10/27/2011US20110262921 Test for the Detection of Bladder Cancer
10/27/2011US20110262919 Method for pretreating specimen and method for assaying biological substance
10/27/2011US20110262917 Modified nucleotides
10/27/2011US20110262913 Marking
10/27/2011US20110262906 Microfluidic multiplexed cellular and molecular analysis device and method
10/27/2011US20110262897 Imaging techniques using a tridentate ligand
10/27/2011US20110262896 System and method for multi-analyte detection
10/27/2011US20110262893 Separating target analytes using alternating magnetic fields
10/27/2011US20110262892 Methods for detection or measurement of viruses
10/27/2011US20110262565 PIP-2 Inhibition-Based Antiviral and Anti-Hyperlipidemic Therapies
10/27/2011US20110262488 Novel HIV-1 Envelope Glycoprotein
10/27/2011US20110262485 Sting (stimulator of interferon genes), a regulator of innate immune responses
10/27/2011US20110262479 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
10/27/2011US20110262475 Lyme disease vaccine
10/27/2011US20110262464 Compositions, Kits, and Methods for the Diagnosis, Prognosis, and Monitoring of Cancer Using GOLPH3
10/27/2011US20110262463 Syngr4 for target genes of cancer therapy and diagnosis
10/27/2011US20110262454 Novel anti-cd38 antibodies for the treatment of cancer
10/27/2011US20110262451 Modulators of isovaleryl-coenzyme a dehydrogenase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
10/27/2011US20110262450 Modulators of monoglyceride lipase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
10/27/2011US20110262447 Human synthetic single-chain antibodies directed against the common epitope of mutant p53 and their uses
10/27/2011US20110262444 Form-specific antibodies for nag-1 (mic-1, gdf-15), h6d and other tgf-beta subfamily and heart disease and cancer diagnoses
10/27/2011US20110262439 Bispecific single chain antibodies with specificity for high molecular weight target antigens
10/27/2011US20110262429 Human timp-1 antibodies
10/27/2011US20110262426 Methods and kits used in identifying glioblastoma
10/27/2011US20110262425 Therapeutic agent for mll leukemia and moz leukemia of which molecular target is m-csf receptor, and use thereof
10/27/2011US20110262360 Compositions Comprising Enzyme-Cleavable Phenol-Modified Opioid Prodrugs and Inhibitors Thereof
10/27/2011US20110262359 Compositions comprising enzyme-cleavable prodrugs of active agents and inhibitors thereof
10/27/2011US20110262358 Molecular marker for cancer stem cell
10/27/2011US20110262355 Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
10/27/2011US20110262350 Breast endothelial cell expression patterns
10/27/2011US20110262305 Vessel with RFID Tag
10/27/2011US20110262304 Method of fluid control in medical diagnostic media
10/27/2011US20110262029 System and method for detecting solder paste printing
10/27/2011US20110261641 Method for controlling loading of foods in a food mixing unit and corresponding control apparatus
10/27/2011US20110260049 Method And Apparatus For Identifying Proteins In Mixtures
10/27/2011US20110259744 Sensors for biomolecular detection and cell classification
10/27/2011US20110259741 Biosensor
10/27/2011US20110259350 Methods of Using SDF-1 (CXCL12) as a Diagnostic and Mesenchymal Stem Cell (Multipotent Stromal Cell)-Specific Therapeutic Biomarker for the Treatment of Kidney Injury and Other Major Organs
10/27/2011US20110259194 System for preventing contaminants from reaching a gas purifier
10/27/2011US20110259128 Integrity Evaluation of Prestressed Concrete Girders
10/27/2011US20110259088 High water content fuel detection system
10/27/2011US20110259084 Gas sensor unit
10/27/2011DE102010018965A1 Bestimmung von Wechselwirkungen zwischen einer Substanz oder einem Substanzgemisch und einem Target Determination of interactions between a substance or mixture of substances and a target
10/27/2011DE102010018636A1 Verfahren und Anordnung für einen markerlosen Enwegtest Method and apparatus for a non-marking Enwegtest
10/27/2011DE102010018249A1 Handprüfgerät und Handprüfverfahren zur Beschaffenheitsuntersuchung von Holz Hand Tester and manual test method for texture analysis of wood
10/27/2011DE102010018085A1 Verfahren zur Erkennung einer Salmonelleninfektion A method for detecting Salmonella infection
10/27/2011CA2796666A1 Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof
10/27/2011CA2796086A1 Detection and analysis of epigenetic and genetic changes in tumor tissue
10/27/2011CA2795222A1 Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
10/27/2011CA2794556A1 Novel allergen
10/27/2011CA2794418A1 Functionalizing biosensors using a multiplexed dip pen array
10/27/2011CA2774618A1 Methods and devices for assessing infertility and/or egg quality
10/26/2011EP2381382A1 Method and apparatus for analysis of molecular configurations and combinations
10/26/2011EP2381259A1 Liver disease marker, method and apparatus for measuring same, and test method for pharmaceutical preparation
10/26/2011EP2381258A1 Microfluidic system with sample pre-treatment
10/26/2011EP2381257A1 Sequential analysis of biological samples
10/26/2011EP2381256A1 Mammalian sweet and amino acid heterodimeric taste receptors
10/26/2011EP2381255A1 Microwell array chip and its manufacturing method
10/26/2011EP2381254A1 Copolymer assay
10/26/2011EP2381253A2 Apparatus for detecting toxicity in water using sulfur-oxidizing bacteria
10/26/2011EP2381249A2 Biomass monitor probes and bioreactors incorporating such probes
10/26/2011EP2381247A1 Method and apparatus for scanning the internal quality of logs
10/26/2011EP2381242A1 Quantitative, multispectral image analysis of tissue specimens stained with quantum dots
10/26/2011EP2381116A1 Apparatus and methods for conducting assays and high throughput screening
10/26/2011EP2380989A1 Method and reagent for determining mevalonic acid, 3-hydroxymethylglutaryl-coenzyme a and coenzyme a
10/26/2011EP2380913A1 Novel anti-IGF-IR antibodies and uses thereof
10/26/2011EP2380912A1 Novel anti-IGF-IR antibodies and uses thereof
10/26/2011EP2380906A2 Artificial antibody polypeptides
10/26/2011EP2380903A1 Differential in tumour gene products and use of same
10/26/2011EP2380900A1 Isolation and use of ryanodine receptors
10/26/2011EP2380899A1 Isolation and use of ryanodine receptors
10/26/2011EP2380646A1 Apparatus and process to characterize dissolved gas in liquid
10/26/2011EP2380583A1 Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
10/26/2011EP2380027A1 Diagnostic prediction of rheumatoid arthritis and systemic lupus erythematosus
10/26/2011EP2380026A1 Assay for troponin i using magnetic labels
10/26/2011EP2380025A2 Ratio based biomarkers and methods of use thereof
10/26/2011EP2380024A1 Armet as a marker for cancer
10/26/2011EP2380023A2 Oxidized cardiolipin as a novel pro-inflammatory factor